How Is IDEX's Stock Performance Compared to Other Industrial Stocks?
/Idex%20Corporation%20logo%20and%20lab%20sign-by%20viewimage%20via%20Shutterstock.jpg)
With a market cap of $14 billion, IDEX Corporation (IEX) is a global leader in applied solutions, specializing in advanced fluid and metering technologies, precision health and science solutions, and fire and safety equipment. With a diverse portfolio spanning industries such as life sciences, industrial processing, firefighting, and aerospace, IDEX delivers high-performance, mission-critical components and systems.
Companies valued at $10 billion or more are generally considered “large-cap” stocks, and IDEX fits this criterion perfectly. Known for its innovation and engineering excellence, the Northbrook, Illinois-based company plays a vital role in powering essential industries with highly specialized and precision-engineered products.
IEX saw a 24.8% decline from its 52-week high of $245.70. Shares of the company declined 13.3% over the past three months, a steeper fall compared to the Industrial Select Sector SPDR Fund’s (XLI) marginal dip over the same time frame.
In the longer term, IEX stock is down 11.7% on a YTD basis, lagging behind XLI’s 1.4% rise. In addition, shares of IDEX have dropped 23.7% over the past 52 weeks, compared to XLI’s 7.8% return over the same time frame.
IEX has been trading below its 50-day and 200-day moving average since mid-December 2024.
Despite reporting a better-than-expected Q4 2024 adjusted EPS of $2.04 on Feb. 4, shares of IDEX tumbled 9.6% the next day. The company's Q1 2025 adjusted EPS guidance of $1.60 - $1.65 fell significantly short of analysts' estimate. In addition, revenue of $862.9 million, while up 9% year-over-year, missed expectations, disappointing investors.
However, its rival, Eaton Corporation plc (ETN) has declined 14% on a YTD basis, underperforming IEX. But, ETN fell 8.5% over the past 52 weeks, a smaller drop than IEX.
Despite IDEX’s underperformance over the past year, analysts remain moderately optimistic about its prospects. The stock has a consensus rating of “Moderate Buy” from 11 analysts' coverage, and as of writing, IEX is trading below the mean price target of $234.10.
On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.